Scope of application of programmes for medical devices including artificial intelligence and insurance coverage

Published:
While the direction of the approved programme medical devices for listing on insurance has been clarified, market-entry and evaluation difficulties continue to be difficult for those without evidence.

Recommendations

  • The EBC requests predictability development based on the idea of risk sharing by utilizing the regenerative medicine system and combining it with external Insurance therapy.